COMMUNIQUÉS West-GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24/07/2026
NOVATO, Calif., July 24, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare [...]
ColestZen Publishes Ingredient Facts for Its 18-Ingredient Supplement Formula: Serving Directions and Safety Information for 2026
24/07/2026
ColestZen's Bitter Melon, Cinnamon, Licorice, and Gymnema Sylvestre Ingredient Forms Tallmadge, OH, July 24, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration. [...]
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency
24/07/2026
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securities Deficiency IRVINE, California – July 24, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the “Company” or “ [...]
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
24/07/2026
ROCKVILLE, Md., July 24, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant [...]
Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders
24/07/2026
DURHAM, N.C., July 24, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS) (the “Company” or “Pelthos”) today announced that it will hold its 2026 Annual Meeting of Stockholders virtually on Tuesday [...]
HorseFil Publishes Full Milligram Amounts for All Seven Ingredients: Tongkat Ali 200 mg, Serving Directions, and Safety Information for 2026
25/07/2026
HorseFil's Tongkat Ali, Maca Root, Ashwagandha, and Horny Goat Weed Amounts Per Gummy Ogden, UT, July 24, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration. HorseFil [...]
Dyadic Announces Continued Listing on the Nasdaq Capital Market
24/07/2026
JUPITER, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions [...]
Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union
24/07/2026
Company plans to request re-examination following negative CHMP opinion for arimoclomol MAA Zevra continues to support access to arimoclomol for eligible patients through its global Expanded Access Program BOSTON, July [...]
BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe
24/07/2026
Collaboration expands Zorronet's AI-powered detection, analysis and response capabilities into agricultural security, theft and critical transportation infrastructure protection NETANYA, Israel, July 24, 2026 (GLOBE [...]
Ondra Health Names Every Pharmacy That Fills Its GLP-1 Prescriptions, a Disclosure Most Telehealth Platforms Don't Make
24/07/2026
Patients are told to verify their provider before starting GLP-1 treatment. The Los Angeles-based platform publishes its five licensed compounding pharmacies, the prescribing medical group, and full pricing so that [...]
Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026
24/07/2026
SYDNEY, AUSTRALIA, July 24, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announced [...]
Amwell® to report second quarter 2026 operating results
24/07/2026
BOSTON, July 24, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2026 operating results [...]
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
24/07/2026
- Positive CHMP opinion supports potential commercialization of obicetrapib monotherapy and obicetrapib/ezetimibe fixed-dose combination in Europe - - Recommendation based on positive Phase 3 BROADWAY, BROOKLYN, and [...]
Magnendo Secures $18M Series A Financing to Transform Endovascular Access for Stroke Intervention
24/07/2026
MIT spinout to accelerate product development and first-in-human studies of its magnetic robotic navigation platform designed to dramatically improve the speed and reliability of neuro-endovascular procedures NEWTON, [...]
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study
24/07/2026
Data demonstrate the ability to detect, localize and confirm changes in renal neural activity, supporting continued development of physiology-guided renal denervation THE WOODLANDS, TX, July 24, 2026 (GLOBE NEWSWIRE [...]
NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease
24/07/2026
Recommendation based on NEXUS data; Minoryx and Neuraxpharm expect European Commission approval by the end of this quarter BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 (GLOBE NEWSWIRE) -- Minoryx Therapeutics [...]
hear.com Honored as Gold Stevie® Award Winner in 2026 Stevie Awards for Technology Excellence
24/07/2026
Award recognizes Horizon IX hearing aids and Clinic-in-a-Box® tele-audiology for expanding access to hearing care nationwide MIAMI, July 24, 2026 (GLOBE NEWSWIRE) -- hear.com , a global innovator in hearing care, has [...]
Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction
24/07/2026
Represents significant milestone in the Company’s ongoing portfolio optimization efforts BRENTWOOD, Tenn., July 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a [...]
Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies
24/07/2026
CEO Discusses Why the Future of Cancer Treatment May Belong to Combination Approaches and How ERNA-101 Was Designed to Turn Immunologically "Cold" Tumors Into Targets for the Immune System Video Showcases Differentiated [...]

Pages